OBJECTIVE: The objective of the study was to compare perinatal outcomes among women diagnosed with gestational diabetes by the National Diabetes Data Group (NDDG) criteria with women meeting only Carpenter-Coustan criteria. STUDY DESIGN: This was a 14 year retrospective cohort. Women who screened positive with 1 hour glucose load 140 mg/dL or greater underwent a diagnostic 3 hour oral glucose tolerance test. We report adjusted prevalence ratios (aPRs) of perinatal outcome risk. RESULTS: Of the 4659 screen-positive women with diagnostic testing, 1082 (3.3%, of 33,179) met NDDG criteria; 1542 (4.6%, of 33,179), or 460 more, met Carpenter-Coustan criteria. These 460 untreated women had greater risk of preeclampsia than women diagnosed by NDDG criteria (aPR, 1.70; 95% confidence interval [CI], 1.23-2.35). They had a greater risk of cesarean delivery (aPR, 1.16; 95% CI, 1.04-1.30) and infants greater than 4000 g (aPR, 1.25; 95% CI, 1.01-1.56) than women not meeting either diagnostic criteria. CONCLUSION: The 42.5% additional women diagnosed only by Carpenter-Coustan criteria are at greater risk for some adverse outcomes. Cost-effectiveness of a change remains to be determined.
OBJECTIVE: The objective of the study was to compare perinatal outcomes among women diagnosed with gestational diabetes by the National Diabetes Data Group (NDDG) criteria with women meeting only Carpenter-Coustan criteria. STUDY DESIGN: This was a 14 year retrospective cohort. Women who screened positive with 1 hour glucose load 140 mg/dL or greater underwent a diagnostic 3 hour oral glucose tolerance test. We report adjusted prevalence ratios (aPRs) of perinatal outcome risk. RESULTS: Of the 4659 screen-positive women with diagnostic testing, 1082 (3.3%, of 33,179) met NDDG criteria; 1542 (4.6%, of 33,179), or 460 more, met Carpenter-Coustan criteria. These 460 untreated women had greater risk of preeclampsia than women diagnosed by NDDG criteria (aPR, 1.70; 95% confidence interval [CI], 1.23-2.35). They had a greater risk of cesarean delivery (aPR, 1.16; 95% CI, 1.04-1.30) and infants greater than 4000 g (aPR, 1.25; 95% CI, 1.01-1.56) than women not meeting either diagnostic criteria. CONCLUSION: The 42.5% additional women diagnosed only by Carpenter-Coustan criteria are at greater risk for some adverse outcomes. Cost-effectiveness of a change remains to be determined.
Authors: Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson Journal: N Engl J Med Date: 2005-06-12 Impact factor: 91.245
Authors: Dana Dabelea; Janet K Snell-Bergeon; Cynthia L Hartsfield; Kimberly J Bischoff; Richard F Hamman; Robert S McDuffie Journal: Diabetes Care Date: 2005-03 Impact factor: 19.112
Authors: A Ferrara; N S Weiss; M M Hedderson; C P Quesenberry; J V Selby; I J Ergas; T Peng; G J Escobar; D J Pettitt; D A Sacks Journal: Diabetologia Date: 2006-11-14 Impact factor: 10.122
Authors: Kimberly K Vesco; Andrea J Sharma; Joanna Bulkley; Terry Kimes; William M Callaghan; Lucinda J England; Mark C Hornbrook Journal: Diabetes Res Clin Pract Date: 2019-05-04 Impact factor: 5.602
Authors: H David McIntyre; Boyd E Metzger; Donald R Coustan; Alan R Dyer; David R Hadden; Moshe Hod; Lynn P Lowe; Jeremy J N Oats; Bengt Persson Journal: Curr Diab Rep Date: 2014-06 Impact factor: 4.810
Authors: Erica K Berggren; Lisa Mele; Mark B Landon; Catherine Y Spong; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; Anthony Sciscione; Patrick Catalano; Margaret Harper; George Saade; Steve N Caritis; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa Journal: Obstet Gynecol Date: 2012-11 Impact factor: 7.661